首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Expert review of anticancer therapy

缩写:EXPERT REV ANTICANC

ISSN:1473-7140

e-ISSN:1744-8328

IF/分区:3.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引3206
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Megan Kassick,Debanjan Pain,Kelly Becht et al. Megan Kassick et al.
Introduction: Rising cancer incidence disproportionately affects low- and middle-income countries (LMICs). Brachytherapy (BT), a form of radiotherapy (RT), is an important modality in the treatment of cervical cancer and ...
Manabu Natsumeda,Masayasu Okada,Satoshi Nakata et al. Manabu Natsumeda et al.
Introduction: Schlafen11 (SLFN11) has emerged as a powerful biomarker of sensitivity to DNA-damaging agents in various cancers. However, not much is known about its role in brain tumors. Conflicting reports show that it i...
Lynershia Sundara Raj Retna Bai,Ancilin Joseph,Fernisha Sundara Raj Retna Bai Lynershia Sundara Raj Retna Bai
Background: Lung cancer remains the most significant cause of cancer-related death worldwide due to the critical challenges in diagnosis. Despite the promising efforts, the existing models faced challenges in capturing th...
John P Micha,Randy D Bohart,Bram H Goldstein John P Micha
Introduction: Endometrial cancer is the most frequently diagnosed gynecologic malignancy and predominantly associated with favorable clinical outcomes. However, advanced or recurrent endometrial cancer is significantly mo...
Greta Catani,Luz D Juez,Juan M O Connor et al. Greta Catani et al.
Introduction: Early-onset gastrointestinal (GI) cancers, defined as those diagnosed before the age of 50, are increasing worldwide, whereas the incidence of late-onset GI cancers has stabilized or declined. These trends h...
Kate McKendry,Corinne Maurice-Dror,Kim N Chi Kate McKendry
Introduction: Metastatic prostate cancer is a leading cause of global cancer-related mortality. Contemporary treatment strategies are increasingly guided by genomic analyses, which are typically performed on archival or n...
Simone Rota,Melanie Claps,Eleonora Gusmaroli et al. Simone Rota et al.
Introduction: The treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC) has changed substantially with the introduction of androgen receptor pathway inhibitors (ARPIs), which have improved survival o...
Takehiro Okabayashi,Ryo Inada,Motoyasu Tabuchi et al. Takehiro Okabayashi et al.
Introduction: Precision oncology has transformed cancer care by enabling biomarker-guided therapeutic strategies; however, durable clinical benefit remains limited across many tumor types. Emerging evidence suggests that ...